Navigation Links
MiMedx Announces Record Third Quarter Results
Date:10/30/2013

MARIETTA, Ga., Oct. 30, 2013 /PRNewswire/ -- MiMedx Group, Inc.  (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today its results for the quarter ended September 30, 2013.

Highlights of third quarter of 2013 results include:

  • Revenue exceeds high end of guidance (8th consecutive quarter of meeting or exceeding upper end of guidance)
  • Revenue increased more than 100% over third quarter of 2012
  • Nine-month revenue increased nearly 150% over same period of 2012
  • 7th consecutive quarter of positive Adjusted EBITDA
  • Quarterly Cash Flow from Operations Positive for the First time in Company History
  • Company reiterates increased lower end of 2013 full year revenue guidance
  • Third Quarter 2013 Results
    The Company recorded record revenue for the quarter ended September 30, 2013, with revenue of $16.1 million, an increase of more than 100% over third quarter of 2012 revenue of $8.0 million. The Company's third quarter gross margins were 87% as compared to gross margins of 82% in the third quarter of last year.  Earnings before interest, taxes, depreciation, amortization and share based compensation (Adjusted EBITDA*) for the third quarter of 2013 were $1.9 million, a $1.1 million  or  156% improvement, as compared to the Adjusted EBITDA of $726,000 for the third quarter of 2012. The Net Loss for the third quarter of 2013 was $307,000 as compared to net loss of $4.2 million in the prior year third quarter. The prior year Net Loss included a $1.8 million Intangible Asset impairment charge and a $1.3 million charge related to the fair value adjustment of the earn-out liability related to the acquisition of Surgical Biologics. 

    <
    '/>"/>
    SOURCE MiMedx
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related biology technology :

    1. MiMedx Reports On Meeting With FDA
    2. MiMedx Responds To Misleading And Inaccurate Media Reports
    3. MiMedx Plantar Fasciitis Study Published In The Foot & Ankle International Journal
    4. MiMedx To Present At 33rd Annual Canaccord Genuity Growth Conference
    5. Mimedx Scientific Study Is Electronically Published in The International Wound Journal
    6. MiMedx Announces Record Second Quarter Results
    7. BioTech Companies in the News - Alliqua, Transition Therapeutics, Organovo, MiMedx Group, Keryx Biopharmaceuticals
    8. MiMedx To Exceed High End Of Second Quarter Guidance
    9. MiMedx to Ring NASDAQ Stock Market Opening Bell
    10. MiMedx to Present at Jefferies 2013 Global Healthcare Conference
    11. MiMedx Secures a $3.0 Million Revolving Line of Credit with Bank of America
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:4/20/2015)... 20, 2015   Meditope Biosciences, Inc ., a ... technology, today announced presentation of data demonstrating the use ... antibody-drug conjugates (ADCs). The data were presented in an abstract ... 18-22 in Philadelphia . ... point to the many commercial applications that may be ...
    (Date:4/20/2015)... Whitehouse Laboratories is pleased and overly excited to announce ... Drug Administration (FDA) inspection and received no observations and ... inspection, as based upon 21CFR Parts 210 and 211 ... was granted NAI (no action indicated) status. The inspection ... Practice (GMP) quality system required by the regulatory agency. ...
    (Date:4/17/2015)... , April 17, 2015  Centrillion ... a SBIR grant from the National Human ... Institutes of Health (NIH). The grant will ... in the development of breakthrough genomic technologies, ... specially fabricated substrates. Centrillion has been developing ...
    (Date:4/17/2015)... CIO Review ( http://www.cioreview.com ) has chosen MMIS ... and Life Science Technology Solution Providers 2015. The positioning ... for life sciences companies. , The annual list ... and members of CIO Review’s editorial board to recognize ... on our radar for some time now for stirring ...
    Breaking Biology Technology:Meditope Biosciences Presents Data At The American Association Of Cancer Research (AACR) Annual Meeting Validating Its SnAP Technology Platform 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 2Whitehouse Laboratories Completes FDA Inspection with No Form 483 – No Observations 3MMIS Chosen by CIO Review as Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2015 2
    ... WILMINGTON, Delaware, November 3 ... Advanced Technologies Market, (2009 - 2014),published by MarketsandMarkets ... global stem cell market. It identifies and analyzes,the ... various,products, services, technologies, and applications submarkets in different,geographic ...
    ... has won a $4.4 million grant from the ... (ARPA-E) to lead a multidisciplinary, multi-institutional research project ... magnets. Stronger magnets are essential for increasing ... and communications systems in the 21st-century, and for ...
    ... The World Egg Bank (TWEB), an international ... announced a first-of-its-kind partnership with a European fertility clinic to ... of donated frozen eggs at or less than the cost ... is between TWEB and IVI in Alicante, Spain, the world,s ...
    Cached Biology Technology:MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014 2MarketsandMarkets: Global Stem Cell and Advanced Technologies Market Worth US$ 88.3 Billion By 2014 3UD wins $4.4 million to develop next-generation magnets 2World Egg Bank Launches Medical Tourism Program With World's Largest Egg-Donation Fertility Clinic 2
    (Date:4/10/2015)... Research and Markets ( http://www.researchandmarkets.com/research/cjk4gb/security ) has ... - NEC" report to their offering. ... to supply a range of IT security management and ... on the development of a Big Data and cloud ... Asia-Pacific region is a core ...
    (Date:4/2/2015)... HAMBURG, Germany , April 2, 2015 /PRNewswire/ ... ten fingerprint tests DERMALOG by far outperforms the ... While always maintaining high accuracy, the system is ... second. Hence, the speed proves up to be ... 40% faster than its runner-up performance. ...
    (Date:4/1/2015)... OXFORD, Conn. , Apr. 1, 2015  NXT-ID, ... a biometric authentication company focused on the growing mobile ... number of Wocket smart wallets is underway to early ... early access group includes usage at retail outlets including ... CVS Pharmacy. Users report Wocket was accepted at all ...
    Breaking Biology News(10 mins):NEC Security Competitive Profile 2015 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
    ... Short courses of antibiotics can leave normal gut bacteria ... after treatment, say scientists writing in the latest issue ... The researchers believe that this reservoir increases the chances ... their survival and suggesting that the long-term effects of ...
    ... seen as a triumph for the preservation of nature, yet ... world,s largest protected areas encompass vast amounts of wilderness but ... or include unusually large numbers of birds, amphibians, or mammals, ... BioScience . The study, by Lisette Cant-Salazar and Kevin ...
    ... researchers have shown how a protein called perforin punches holes ... of the mechanism of this assassin is published today in ... weapon of cleansing and death," says project leader Prof James ... have been hijacked by viruses or turned into cancer cells ...
    Cached Biology News:Antibiotics have long-term impacts on gut flora 2How do we kill rogue cells? 2
    ... Hot Start Taq ... activity before the onset ... nonspecific amplification and primer-dimer ... is raised, the antibody ...
    ... Fluorescein 6-Fam, Hex, Tet Cy3, Cy5, ... Tamra Black Hole Quenchers Molecular Beacons* ... Tamra, Joe 3 Dabcyl Dabcyl*Licensed ... York Double labelled probes are purified either ...
    ... (rEK) is a highly purified preparation of ... serine protease which recognizes the identical cleavage ... has similar enzymatic activity (1). Novagen&'s enzyme ... to yield the highest activity available, and ...
    Angiotensin Converting Enzyme [Porcine Kidney, ACE, Peptidyl-dipeptidase A]...
    Biology Products: